Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy

Immunotherapy is an attractive approach for treating cancer. T‐cell engagers (TCEs) are a type of immunotherapy that are highly efficacious; however, they are challenged by weak T‐cell activation and short persistence. Therefore, alternative solutions to induce greater activation and persistence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhallak, Kinan, Sun, Jennifer, Muz, Barbara, Jeske, Amanda, O’Neal, Julie, Ritchey, Julie K., Achilefu, Samuel, DiPersio, John F., Azab, Abdel Kareem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817130/
https://www.ncbi.nlm.nih.gov/pubmed/35014164
http://dx.doi.org/10.1111/jcmm.16885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817130/
https://www.ncbi.nlm.nih.gov/pubmed/35014164
http://dx.doi.org/10.1111/jcmm.16885

Ejemplares similares